Drug intelligence / Profile preview

tiaoganlipi prescription granules

Development stage
Unknown
Lead developer
Beijing Hospital of Traditional Chinese Medicine
Administration
Oral
01

Overview

Tiaoganlipi prescription granules is a Traditional Chinese Medicine (TCM) formulation developed by the Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University. It is primarily indicated for the treatment of gastroesophageal reflux disease (GERD) and its associated laryngopharyngeal reflux disease (LPRD). The prescription is based on the TCM therapeutic principle of "regulating the liver and strengthening the spleen" (Tiao Gan Li Pi) to address the underlying disharmony believed to cause reflux symptoms. In clinical trials, it is often administered as an oral granule in combination with proton pump inhibitors (PPIs) like omeprazole to enhance symptomatic relief and improve patient outcomes.

Other names
Tiaoganlipi prescriptionTiaoganlipi formulaTiaoganlipi prescription granules
02

Targets

ABL1 (ABL proto-oncogene 1, non-receptor tyrosine kinase)CCNA2 (Cyclin A2)CCNB1 (Cyclin B1)CDK4 (Cyclin-dependent kinase 4)EP300 (Histone acetyltransferase p300 (EP300) catalytic domain)IGF-1R (Insulin-like growth factor 1 receptor)MEK1 (Dual specificity mitogen-activated protein kinase kinase 1)PR (Progesterone receptor)

Beyond the preview

Go deeper on tiaoganlipi prescription granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tiaoganlipi prescription granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call